GREGoRi Technology Integration Center (U01, Clinical Trials Optional)
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The National Human Genome Research Institute (NHGRI) is preparing to release a Notice of Funding Opportunity (NOFO) aimed at renewing its Genomics Research to Elucidate the Genetics of Rare Disease program under a new initiative called GREGoR: Innovation (GREGoRi). This initiative is designed to revolutionize the diagnosis of rare diseases by introducing innovative tools, molecular technologies, and analytical methods to better identify the genes or variants responsible for these conditions. Central to this effort is the establishment of the GREGoRi Technology Integration Center (TechIC), which will focus on developing standards and best practices for implementing cutting-edge molecular approaches in rare disease diagnosis. A key output of the Center will be the creation of a comprehensive multidimensional dataset to support the development and benchmarking of new diagnostic tools and methodologies. The NOFO is scheduled to be published in 2025, with applications expected by 2026, and will use the U01 cooperative agreement activity code, indicating a collaborative research project. This advance notice is intended to give prospective applicants adequate time to form collaborations and design responsive projects. The contracting agency is the National Institutes of Health, specifically under the Department of Health and Human Services, with contact available through Lisa H. Chadwick at NHGRI. The initiative’s goal is to accelerate breakthroughs in rare disease genomics by integrating novel technologies and fostering innovation in the field.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
The National Human Genome Research Institute (NHGRI) intends to promote a new initiative by publishing a Notice of Funding Opportunity (NOFO) to renew the Genomics Research to Elucidate the Genetics of Rare Disease (GREGoR) program. The renewal, called GREGoR: Innovation (GREGoRi), seeks to accelerate a paradigm shift in rare disease diagnosis by reimagining the tools, molecular technologies and analytical approaches used to identify the causal gene(s) and/or variant(s) underlying rare genetic disorders. The purpose of this NOFO is to establish the GREGoRi Technology Integration Center (TechIC), which will enable the development of standards and best practices for applying new and emerging molecular methods in rare disease diagnosis. A major deliverable of the Center will be a multidimensional dataset that can be used for the development and benchmarking of novel tools and strategies that facilitate rare disease diagnosis.
This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. The NOFO is expected to be published in 2025 with an expected application due date in 2026. This NOFO will utilize the U01 activity code.